Abbott Laboratories vs. Shuttle Pharmaceuticals Holdings, Inc. Common Stock
ABT
Abbott Laboratories
$101.07 -2.34%
VS SHPHShuttle Pharmaceuticals Holdings, Inc. Common Stock
$4.00 +11.42%
Abbott Laboratories (ABT) comes out ahead, leading on 6 of 9 compared factors.
Size & Scale
| ABT | SHPH | |
|---|---|---|
| Market Cap | $179.08 billion | $2.10 million |
| Revenue (TTM) | $46.59 billion | $-9,516,824 |
| Net Income (TTM) | $5.42 billion | $-10,827,907 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | SHPH | |
|---|---|---|
| P/E Ratio | 32.71 | 400.00 |
| Price / Book | 3.46 | 0.63 |
| Price / Sales | 3.84 | -0.22 |
SHPH leads on 2 of 3 valuation factors.
Profitability
| ABT | SHPH | |
|---|---|---|
| Net Margin | 11.65% | 113.78% |
| Return on Equity | 10.48% | -323.58% |
ABT and SHPH split the profitability factors evenly.
Dividend
| ABT | SHPH | |
|---|---|---|
| Dividend Yield | 2.49% | — |
| Payout Ratio | 81.55 | — |
ABT and SHPH split the dividend factors evenly.
Risk & Sentiment
| ABT | SHPH | |
|---|---|---|
| Short Interest | 0.57% | 11.25% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, SHPH overview, SHPH financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.